Publications

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

AuthID
P-00P-JH3

Author(s)

Tilly, H

Morschhauser, F

Casasnovas, O

Molina, TJ

Feugier, P

Le Gouill, S

Haioun, C

Tournilhac, O

Bouabdallah, R

Gabarre, J

Lamy, T

Cabecadas, J

Becker, S

Jardin, F

Mounier, N

Salles, G

Group Author(s)

Lymphoma Study Assoc

Document Type

Article

Year published

2018

Published

in LANCET HAEMATOLOGY, ISSN: 2352-3026

Volume: 5, Issue: 9, Pages: E403-E410 (8)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s2352-3026(18)30131-5

SCOPUS: 2-s2.0-85052473352

Wos: WOS:000443210100011

Source Identifiers

ISSN: 2352-3026

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Lenalidomide in Combination with R-Chop (R2-Chop) as First-Line Treatment of Patients with High Tumour Burden Follicular Lymphoma: a Single-Arm, Open-Label, Phase 2 Study

Useful Links

Get Help